This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Examining the potential of Tarsus Pharma's TP-03 in treating Demodex blepharitis
Ticker(s): TARSWho's the expert?
Institution: The Eye Care Institute
- Ophthalmologist/Surgeon at The Eye Care Institute in Louisville KY.
- Fellowship trained at Emory University School of Medicine in Cornea, External Diseases and Refractive Surgery.
- Investigator on the TP-03 trial and treats over 100 patients with demodex blepharitis; Averages 50 intraocular procedures a month and has used both Dextenza and Dexycu.
Interview GoalThis conversation will discuss TP-03 , a topical ophthalmic preparation of an established acaricide currently in development by Tarsus Pharma.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
